Capsule endoscopy (CE), introduced in 2000 and FDA-approved in 2001, remains a valuable tool for diagnosing gastrointestinal (GI) lesions, particularly in areas inaccessible to traditional endoscopy. While CE offers non-invasive imaging and improves detection of small bowel diseases and obscure GI bleeding, its widespread use is hindered by limitations such as lack of therapeutic capabilities, inability to obtain biopsies, reliance on peristalsis for movement, and time-consuming image interpretation.
Trending
- EndoQuest Robotics Announces Completion of Enrollment in the PARADIGM Trial (Business Wire)
- A single blood sample may improve the prediction of colorectal cancer recurrence or metastasis, kaist study finds (EurekAlert)
- At-Home Colorectal Cancer Tests Are Not a One-and-Done Deal (Cancer Health)
- How AI clears the way for colonoscopy screening (American Medical Association)
- Inside Diverticulitis: What Gastroenterologists Need to Know (Medscape)
- Abbott reports diagnostics growth since $21B Exact Sciences buy (Medtech Dive)
- Video Capsule Endoscopy Has Widening Role Beyond Diagnosis of Small-Bowel Bleeding (GI & Endoscopy News)
- How the AGA Incubator is shaping the future of digestive health (AGA)
